Year-end Sale % OFF 
Abstract
CRMO is a rare, orphan auto-inflammatory disease characterized by recurrent episodes of pain associated with sterile bone inflammation. There is no consensus on the optimal treatment.
Highlights
chronic recurrent multifocal osteomyelitis (CRMO) is a rare, orphan auto-inflammatory disease characterized by recurrent episodes of pain associated with sterile bone inflammation
Retrospective descriptive case series of nine children diagnosed as CRMO at the Department of Pediatric Rheumatology at Hacettepe University, Ankara, Turkey
Acute phase reactants returned to normal, physician and patient/parent visual analogue scales significantly improved in all patients after etanercept treatment
Summary
CRMO is a rare, orphan auto-inflammatory disease characterized by recurrent episodes of pain associated with sterile bone inflammation. A proposed treatment scheme for chronic recurrent multifocal osteomyelitis (CRMO): a case series of nine patients Objectives The aim of this study was to review our CRMO patients and report our results with etanercept treatment in patients with a resistant course in CRMO. Methods Retrospective descriptive case series of nine children diagnosed as CRMO at the Department of Pediatric Rheumatology at Hacettepe University, Ankara, Turkey.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
